[1] C. H. Tator and M. G. Fehlings, “Review of the secondary injury theory of acute spinal cord traume with emphasis on vascular mechanisms,” J Neurosurg, vol. 75, pp. 15–26, 1991.
[2] N. A. Silva, N. Sousa, R. L. Reis, and A. J. Salgado, “From basics to clinical: A comprehensive review on spinal cord injury,” Prog. Neurobiol., vol. 114, pp. 25–57, 2014.
[3] B. Winter, H. Pattani, and E. Temple, “Spinal cord injury,” Anaesth. Intensive Care Med., vol. 15, no. 9, pp. 424–427, 2014.
[4] T. Haider et al., “The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats,” Exp. Neurol., vol. 267, pp. 230–242, 2015.
[5] M. G. Fehlings and R. G. Perrin, “The role and timing of early decompression for cervical spinal cord injury: Update with a review of recent clinical evidence,” Injury, vol. 36, no. SUPPL. 2, pp. 13–26, 2005.
[6] M. G. Fehlings et al., “Early versus delayed decompression for traumatic cervical spinal cord injury: Results of the surgical timing in acute spinal cord injury study (STASCIS),” PLoS One, vol. 7, no. 2, 2012.
[7] G. Mattiassich et al., “Functional Outcomes in Individuals Undergoing Very Early (< 5 h) and Early (5–24 h) Surgical Decompression in Traumatic Cervical Spinal Cord Injury: Analysis of Neurological Improvement from the Austrian Spinal Cord Injury Study,” J. Neurotrauma, vol. 34, pp. 1–10, 2017.
[8] T. Hausner et al., “Improved rate of peripheral nerve regeneration induced by extracorporeal shock wave treatment in the rat,” Exp. Neurol., vol. 236, no. 2, pp. 363–370, 2012.
[9] D. Lobenwein et al., “Shock Wave Treatment Protects From Neuronal Degeneration via a Toll-Like Receptor 3 Dependent Mechanism: Implications of a First-Ever Causal Treatment for Ischemic Spinal Cord Injury,” J Am Hear. Assoc., pp. 1–13, 2015.
[10] S. Yamaya et al., “Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury,” J. Neurosurg., vol. 121, no. 6, pp. 1514–1525, Dec. 2014.
[11] C. W. L. Chan, J. J. Eng, C. H. Tator, and A. Krassioukov, “Epidemiology of sport-related spinal cord injuries: A systematic review,” J. Spinal Cord Med., vol. 39, no. 3, pp. 255–264, 2016.
[12] B. B. Lee, R. A. Cripps, M. Fitzharris, and P. C. Wing, “The global map for traumatic spinal cord injury epidemiology: Update 2011, global incidence rate,” Spinal Cord, vol. 52, no. 2, pp. 110–116, 2014.
[13] Y. Chen, Y. He, and M. J. DeVivo, “Changing Demographics and Injury Profile of New Traumatic Spinal Cord Injuries in the United States, 1972–2014,” Arch. Phys. Med. Rehabil., vol. 97, no. 10, pp. 1610–1619, 2016.
[14] M. Wyndaele and J. J. Wyndaele, “Incidence, prevalence and epidemiology of spinal cord injury: What learns a worldwide literature survey?,” Spinal Cord, vol. 44, no. 9, pp. 523–529, 2006.
[15] World Health Organization, “International Perspectives on Spinal Cord Injuty,” 2003.
[16] S. A. Patel, A. R. Vaccaro, and J. A. Rihn, “Epidemiology of Spinal Injuries in Sports,” Oper. Tech. Sports Med., vol. 21, no. 3, pp. 146–151, 2013.
[17] K. E. Carll, A. E. Park, and P. J. Tortolani, “Epidemiology of catastrophic spine injuries in high school, college, and professional sports,” Semin. Spine Surg., vol. 22, no. 4, pp. 168–172, 2010.
[18] M. J. DeVivo, “Epidemiology of traumatic spinal cord injury: trends and future implications,” Spinal Cord, vol. 50, no. 5, pp. 365–372, May 2012.
[19] T. Hausner and A. Nógrádi, “The use of shock waves in peripheral nerve regeneration: New Perspectives?,” Int. Rev. Neurobiol., vol. 109, pp. 85–98, 2013.
[20] A. Buss et al., “Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord,” Brain, vol. 128, no. 2, pp. 356–364, 2005.
[21] Z. Zhang and L. Guth, “Experimental spinal cord injury: Wallerian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration,” Exp. Neurol., vol. 147, no. 1, pp. 159–171, 1997.
[22] Y. S. Gwak and C. E. Hulsebosch, “Neuronal hyperexcitability: A substrate for central neuropathic pain after spinal cord injury,” Curr. Pain Headache Rep., vol. 15, no. 3, pp. 215–222, 2011.
[23] B. C. Hains, W. D. Willis, and C. E. Hulsebosch, “Temporal plasticity of dorsal horn somatosensory neurons after acute and chronic spinal cord hemisection in rat,” Brain Res., vol. 970, no. 1–2, pp. 238–241, 2003.
[24] American Spinal Injury Association, “International Standards for Neurological Classification of SCI (ISNCSCI) Exam,” vol. 99, pp. 4–5, 2002.
[25] American Spinal Injury Association, “International Standards for the Classification of Spinal Cord Injury: Motor Exam Guide,” no. June, pp. 1–16, 2008.
[26] American Spinal Injury Association, “International Standards for the Classification of Spinal Cord Injury: Key Sensory Points,” no. June, pp. 1–6, 2009.
[27] F. Högel, J. Vastmans, M. Vogel, and V. Bühren, “Verletzungen des Rückenmarks – Akutbehandlung,” Orthopädie und Unfallchirurgie up2date, vol. 11, no. 06, pp. 451–479, 2016.
[28] R. Mittermayr et al., “Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy.,” Wound Repair Regen., vol. 20, no. 4, pp. 456–65, Jun. 2012.
[29] T. Iskratsch, H. Wolfenson, and M. P. Sheetz, “Appreciating force and shape — the rise of mechanotransduction in cell biology,” Nat. Rev. Mol. Cell Biol., vol. 15, no. 12, pp. 825–833, 2014.
[30] W. Schaden, R. Mittermayr, N. Haffner, D. Smolen, L. Gerdesmeyer, and C. J. Wang, “Extracorporeal shockwave therapy (ESWT) - First choice treatment of fracture non-unions?,” Int. J. Surg., vol. 24, pp. 179–183, 2015.
[31] M. C. D’Agostino, K. Craig, E. Tibalt, and S. Respizzi, “Shock wave as biological therapeutic tool: From mechanical stimulation to recovery and healing, through mechanotransduction,” Int. J. Surg., vol. 24, pp. 147–153, 2015.
[32] S. M. AG, “STORZ MEDICAL’s NEUROLITH® receives CE approval – Transcranial Pulse Stimulation (TPS) on the central nervous system of patients with Alzheimer’s disease,” 2019. [Online]. Available: https://www.storzmedical.com/news-press/entry/neurolith-ce-approval-transcranial-pulse-stimulation-tps-treatment-alzheimer-disease.html. [Accessed: 26-Jan-2019].
[33] H. Lohse-Busch, U. Reime, and R. Falland, “Symptomatic treatment of unresponsive wakefulness syndrome with transcranially focused extracorporeal shock waves,” NeuroRehabilitation, vol. 35, pp. 235–244, 2014.
[34] T. Davis et al., “Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury,” Int. Wound J., vol. 6, pp. 11–21, 2009.
[35] J. Holfeld et al., “Shockwave Therapy Differentially Stimulates Endothelial Cells: Implications on the Control of Inflammation via Toll-Like Receptor 3,” Inflammation, vol. 37, no. 1, pp. 65–70, 2013.
[36] N. G. Sukubo, S. Respizzi, M. Locati, E. Tibalt, and M. C. D’Agostino, “Effect of shock waves on macrophages: A possible role in tissue regeneration and remodeling,” Int. J. Surg., pp. 124–130, 2015.
[37] J. Holfeld et al., “Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle.,” Cardiovasc. Res., vol. 109, no. 2, pp. 331–43, Feb. 2016.
[38] M. Bracken, “Steroids for acute spinal cord injury.,” Cochrane Database Syst Rev, no. 1, p. CD001046, 2012.
[39] F. Chmelizek, H. P. Jonas, A. Kathrein, and C. Knop, “Hochdosiertes Methylprednisolon beim spinalen Trauma - Konsensus Stetement,” Int. Zeitung für ärztliche Fortbildung, vol. 16, no. 2, pp. 1–8, 2006.
[40] R. J. Hurlbert, “Methylprednisolone for acute spinal cord injury: an inappropriate standard of care,” J. Neurosurg. Spine, vol. 168, no. 9, pp. 1–7, 2000.
[41] A. Chen, X. M. Xu, N. Kleitman, and M. B. Bunge, “Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord,” Exp. Neurol., vol. 138, no. 2, pp. 261–276, 1996.
[42] A. Mirea, G. Onose, L. Padure, and E. Rosulescu, “Extracorporeal shockwave therapy (ESWT) benefits in spastic children with cerebral palsy (CP).,” J. Med. Life, vol. 7, no. 3, pp. 127–32, 2014.
[43] E. A. Elster, A. Stojadinovic, J. Forsberg, S. Shawen, R. C. Andersen, and W. Schaden, “Extracorporeal shock wave therapy for nonunion of the tibia,” J. Orthop. Trauma, vol. 24, no. 3, pp. 133–141, 2010.
[44] J. Holfeld et al., “Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation,” PLoS One, vol. 9, no. 8, pp. 1–7, 2014.
[45] E. Brouwers, H. Van De Meent, A. Curt, B. Starremans, A. Hosman, and R. Bartels, “Definitions of traumatic conus medullaris and cauda equina syndrome: A systematic literature review,” Spinal Cord, vol. 55, no. 10, pp. 886–890, 2017.
[46] T. Jaki, P. Pallmann, and D. Magirr, “The R Package MAMS for Designing Multi-Arm Multi-Stage Clinical Trials,” J. Stat. Softw., vol. 88, no. 4, 2019.
[47] J. Whitehead, The Design and Analysis of Sequential Clinical Trials. John Wiley & Sons, 1997.
[48] J. T. C. Hsieh, D. L. Wolfe, W. C. Miller, A. Curt, and SCIRE Research Team, “Spasticity outcome measures in spinal cord injury: psychometric properties and clinical utility,” Spinal Cord, vol. 46, no. 2, pp. 86–95, Feb. 2008.
[49] T. G. Hornby, W. Z. Rymer, E. N. Benz, and B. D. Schmit, “Windup of Flexion Reflexes in Chronic Human Spinal Cord Injury: A Marker for Neuronal Plateau Potentials?,” J. Neurophysiol., vol. 89, no. 1, pp. 416–426, Jan. 2003.
[50] M. M. Adams, K. A. M. Ginis, and A. L. Hicks, “The Spinal Cord Injury Spasticity Evaluation Tool: Development and Evaluation,” Arch. Phys. Med. Rehabil., vol. 88, no. 9, pp. 1185–1192, Sep. 2007.
[51] R. W. Bohannon and M. B. Smith, “Interrater reliability of a modified Ashworth scale of muscle spasticity.,” Phys. Ther., vol. 67, no. 2, pp. 206–7, Feb. 1987.
[52] J. D. Steeves et al., “Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: Clinical trial outcome measures,” Spinal Cord, vol. 45, no. 3, pp. 206–221, 2007.
[53] A. D. Pandyan, G. R. Johnson, C. I. Price, R. H. Curless, M. P. Barnes, and H. Rodgers, “A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity.,” Clin. Rehabil., vol. 13, no. 5, pp. 373–83, Oct. 1999.
[54] B. C. Craven and A. R. Morris, “Modified Ashworth scale reliability for measurement of lower extremity spasticity among patients with SCI,” Spinal Cord, vol. 48, no. 3, pp. 207–213, Mar. 2010.
[55] B. M. Haas, E. Bergström, A. Jamous, and A. Bennie, “The inter rater reliability of the original and of the modified Ashworth scale for the assessment of spasticity in patients with spinal cord injury.,” Spinal Cord, vol. 34, no. 9, pp. 560–4, Sep. 1996.
[56] P. Tederko, M. Krasuski, J. Czech, A. Dargiel, I. Garwacka-Jodzis, and A. Wojciechowska, “Reliability of clinical spasticity measurements in patients with cervical spinal cord injury.,” Ortop. Traumatol. Rehabil., vol. 9, no. 5, pp. 467–83.
[57] H. E. Lechner, A. Frotzler, and P. Eser, “Relationship between self- and clinically rated spasticity in spinal cord injury.,” Arch. Phys. Med. Rehabil., vol. 87, no. 1, pp. 15–9, Jan. 2006.
[58] V. A. B. Scholtes, J. G. Becher, A. Beelen, and G. J. Lankhorst, “Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments.,” Dev. Med. Child Neurol., vol. 48, no. 1, pp. 64–73, Jan. 2006.
[59] L. T. da Silva, “Nine-hole peg test for evaluation of hand function: The advantages and shortcomings,” Neurol. India, vol. 65, no. 5, p. 1033, 2017.
[60] M. J. Mulcahey, B. T. Smith, and R. R. Betz, “Psychometric rigor of the Grasp and Release Test for measuring functional limitation of persons with tetraplegia: a preliminary analysis.,” J. Spinal Cord Med., vol. 27, no. 1, pp. 41–6, 2004.
[61] K. J. Schnake, G. D. Schroeder, A. R. Vaccaro, and C. Oner, “AOSpine Classification Systems (Subaxial, Thoracolumbar),” J. Orthop. Trauma, vol. 31, no. 9, pp. S14–S23, 2017.
[62] AOSpine Research Team, “AOSpine Subaxial Classification System,” 2018.
[63] AOSpine Research Team, “AOSpine Thoracolumbar Classification System,” 2018.
[64] J. Y. You, J. W. Lee, E. Lee, G. Y. Lee, J. S. Yeom, and H. S. Kang, “MR Classification System Based on Axial Images for Cervical Compressive Myelopathy,” Radiology, vol. 276, no. 2, pp. 553–561, 2015.
[65] M. Machino, Y. Yukawa, K. Ito, S. Kanbara, D. Morita, and F. Kato, “Posterior ligamentous complex injuries are related to fracture severity and neurological damage in patients with acute thoracic and lumbar burst fractures,” Yonsei Med. J., vol. 54, no. 4, pp. 1020–1025, 2013.
[66] A. R. Vaccaro et al., “Injury of the posterior ligamentous complex of the thoracolumbar spine: A prospective evaluation of the diagnostic accuracy of magnetic resonance imaging,” Spine (Phila. Pa. 1976)., vol. 34, no. 23, pp. 841–847, 2009.
[67] J. A. Rihn, C. Fisher, J. Harrop, W. Morrison, N. Yang, and A. R. Vaccaro, “Assessment of the posterior ligamentous complex following acute cervical spine trauma,” J. Bone Jt. Surg. - Ser. A, vol. 92, no. 3, pp. 583–589, 2010.
[68] K. F. Schulz and D. A. Grimes, “Blinding in randomised trials: Hiding who got what,” Lancet, vol. 359, no. 9307, pp. 696–700, 2002.